Switching to biosimilar infliximab: real world data in patients with severe inflammatory arthritis. (2018)
Attributed to:
Lifecourse Determinants of Bone and Joint Disease
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
PubMed Identifier: 29352847
Publication URI: http://europepmc.org/abstract/MED/29352847
Type: Journal Article/Review
Volume: 36
Parent Publication: Clinical and experimental rheumatology
Issue: 1
ISSN: 0392-856X